Clinical Trials: Volunteers and New Drug Research Document List
Updated/Revised Date: 2017-11-11
Author: Disabled World | Contact us
Although some of these documents from our Clinical Trials category may have since been updated, re-written, replaced, or revised, they are sorted below by their original publish date. The most recent publications are listed at the top of the table with older articles being listed in descending order by the date they were created.
You can also receive our latest related publications by subscribing to our Clinical Trials RSS feed.
List of Clinical Trials Publications:
Clinical trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) begins enrollment.
New clinical trial testing disease modifying drug for multiple sclerosis (MS) first in the world to recognize importance of wheelchair users retaining use of their hands.
Intensity Therapeutics a private biotech firm is way ahead of big pharma and universities with human cancer immuno oncology clinical trials.
According to research presented at TAT (Targeted Anticancer Therapies) International Congress 2018 in Paris, France - Fighting my cancer as much as possible - is why many patients participate in early stage clinical trials.
Early-phase clinical trial of selumetinib in children with common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas.
Antidote matches the right patients with the right clinical trials, helping medical researchers make faster progress, and offering new treatment options to patients.
U.S. FDA is committed to meet needs of patients and health care communities in prevention, diagnosis, and treatment of cancer.
Asterias Biotherapeutics AST-OPC1 treatment for spinal cord injury patients shown to help paralyzed patients regain function in arms and hands.
We are looking for people who have at least one patch of vitiligo that has appeared or worsened over the past year.
Mental Imagery Therapy for Autism (MITA), an early-intervention application for children with ASD, is currently being validated in the clinical trial.
Clinicians and engineers at University of Kent carrying out first clinical trials of robotic legs for patients.
It is important for more women, particularly those of diverse ethnicities, to take part in clinical trials.
HEADWAY-DLB is a phase 2b multi-center, double-blind, placebo-controlled study to evaluate investigational medicine RVT-101 for dementia with Lewy bodies.
Spinal cord injury researcher is seeking participants with spinal cord injuries for the final phase of her doctoral research.
United Spinal Association recruiting people with spinal cord injury and disease for a study to control and prevent urinary symptoms.
FDA grants breakthrough therapy designation for the investigational medicine Ocrelizumab (OCREVUS) for treatment of primary progressive multiple sclerosis (PPMS).
Results of 3 year clinical trial study of retinal implant known as the Argus II bionic eye for people blinded by retinitis pigmentosa.
Measles vaccine made of fine dry powder delivered with puff of air triggered no adverse side effects in early human testing and it is likely effective.
Transition announce results of clinical study of neuropsychiatric drug candidate ELND005 in young adults with Down syndrome.
IMC-1 oral medication proves highly effective at reducing pain and other symptoms of fibromyalgia (FM) in patients in a recent clinical trial.
This study supports clinical feedback from healthcare professionals regarding positive outcomes with Traumeel and Zeel injections in knee osteoarthritis.
The Glyder Device is designed to provide long-term relief of facet joint pain through a non-fusion procedure.
Researchers at NIAID are conducting early phase trial to evaluate VSV-ZEBOV Ebola virus vaccine.
Clinical trial finds a growth factor known as IGF1 can help treat some symptoms of Rett syndrome.
Recruiting efforts are underway to enroll children between the ages of 2 and 10 diagnosed with cerebral palsy in an FDA regulated clinical trial using stem cell therapy.
Association of American Physicians and Surgeons states EPA is soliciting senior Americans to volunteer for experiments where the purpose is to harm people.
Study identified with potential to improve treatment of a high-risk childhood brain tumor are now part of pediatric clinical trial.
Research from Western University has revealed a possible new target for treating movement disorders such as Huntingtons disease (HD) and Parkinsons disease.
Experts in muscle stimulation technology and brain-computer interfaces working to restore movement for people with paralysis.
First FDA approved clinical trial to evaluate use of child's own cord blood stem cells to treat patients with autism.
Phase 2 clinical trial of SUN13837 an investigational medication developed to improve neurological function in patients with newly diagnosed acute spinal cord injury.
Laquinimod has been shown to be effective in treating the progression of MS for patients with relapsing remitting forms of the disease.
The trial funded by the Wellcome Trust called MUCOVAC2 is evaluating a vaccine that contains the HIV trimeric gp140 protein CN54 representative of Clade C strains of the virus.
Draft guidance designed to help investigators and manufacturers to develop and seek approval for artificial pancreas device systems to treat type 1 diabetes.
Immunicum which is developing cancer vaccines has received approval to test the vaccine on humans for the first time.
Genentech announces data from Phase III clinical trials that assessed efficacy and safety profile at 24 weeks in rheumatoid arthritis patients..
Children and adults with social withdrawal due to Fragile X syndrome or autism may benefit from an experimental drug under study.
Investigational Treatment for Spinal Cord Injury and Traumatic Brain Injury - Acorda Therapeutics Licenses Rights
Acorda plans to study AC105 as an acute treatment for patients who have suffered neurological trauma such as spinal cord injury and traumatic brain injury.
Safety, Tolerability and Pharmacokinetics of SBC-102 in Adult Patients With Lysosomal Acid Lipase Deficiency
Open label dose escalation study in adult patients with liver dysfunction due to Lysosomal Acid Lipase (LAL) Deficiency.
Families of Spinal Muscular Atrophy approval from FDA to commence a Phase I safety study for RG3039 formerly called Quinazoline495 developed for Spinal Muscular Atrophy.
We are encouraged by the clinical effects of SAR 1118 in improving both signs and symptoms of dry eye.
Clinical trials are research studies in which people help doctors find ways to improve health and cancer care.
Phase 1/2a clinical trial testing safety and efficacy of allogeneic cell therapy product SB623 on patients suffering from stable deficits resulting from previous stroke injuries.
NeuroVive announced agreement with European Brain Injury Consortium to conduct clinical trial of NeuroSTAT for neuro-protection in patients with traumatic brain injury (TBI).
More than 500 people suffering from lower arm pain are to take part in a new UK-wide clinical trial.
Neuralstem updated the progress of its ongoing Phase I human clinical trial of spinal cord stem cells in the treatment of ALS.
Study marks the emergence of disease-modifying treatments for autism spectrum disorders.
The Aspirin in Reducing Events in the Elderly study will assess whether aspirin can prolong life and if it can prolong a life free of physical disability and dementia for healthy older people.
Curemark announces it has added two sites in California to its Phase III clinical trial program for CM-AT autism treatment.
Compared with adult cancer patients parents of children with cancer were more likely to be dissatisfied with consent process for participating in clinical trials.
Reovirus that can cause coughing and mild diarrhea appears to have a major redemptive quality - the ability to kill cancer.
Novartis Once-Yearly Reclast Preserves Bone Mass and Fracture Protection in Postmenopausal Osteoporosis
Long-term data show novartis once-yearly reclast preserves bone mass and provides fracture protection in postmenopausal osteoporosis.
New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease.
An experimental vaccine intended to prevent genital herpes disease in women although generally safe and well-tolerated proved ineffective.
Abatacept found ineffective in treatment of non-life threatening lupus further trials needed to determine clinical application of drug in SLE.
New findings from major drug trial a step closer to developing a drug which could prevent thousands of deaths from heart attacks.
First clinical trials on a new drug being developed to treat infections caused by Hepatitis C virus successfully completed.
Evidence of success of apixaban in prevention of stroke in patients with atrial fibrillation who are unsuitable for treatment of warfarin.
Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells.
Study found tapentadol ER was associated with a lower overall incidence of gastrointestinal adverse events than oxycodone CR.
The Alzheimer's Association announced today the launch of Alzheimer's Association TrialMatch.
Study to see if giving Vitamin D to pregnant mother can prevent recurrence of autism in the newborn sibling.
Neurologix Announces Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease.
Curemark is a drug research and development company focused on the treatment of neurological and other diseases.
Clinical trials have started on a new drug which is being developed to treat infections caused by Hepatitis C virus.
First approved clinical study for a Total Spine Arthroplasty system in the U.S..
Multiple sclerosis (MS) trial showed 71 percent of alemtuzumab treated patients remain free of clinically-active disease for three years.
First patients enrolled in cordis trial of new stent graft system to treat abdominal aortic aneurysm.
Clinical research trial of a new treatment to restore brain cells damaged by stroke has passed an important safety stage.
FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinsons Disease.
Immunogenicity data from Pivotal 2009 A/H1N1 VLP pandemic influenza vaccine study in Mexico.
First-in-man clinical trial with its ReN001 stem cell therapy for stroke.
Trial for use of luliconazole in patients with onychomycosis nail and nail bed fungal infections.
Positive Phase 2 Study Results of Perifosine as Single Agent for Treatment of Advanced Waldenstroms Macroglobulinemia.
You're reading Disabled World. See our homepage for informative disability news, reviews, sports, stories and how-tos. You can also connect with us on social media such as Twitter and Facebook or learn more about Disabled World on our about us page.
Disclaimer: Disabled World provides general information only. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.
Cite This Page (APA): Disabled World. (2017, November 11). Clinical Trials: Volunteers and New Drug Research. Disabled World. Retrieved September 21, 2021 from www.disabled-world.com/medical/clinical-trials-2/